Group One Trading
PCVX icon

Group One Trading’s Vaxcyte PCVX Stock Holding History

Group One Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-831
Closed -$45.1K – 9188
2025
Q4 		$38.3K Buy
+831
New +$37.2K ﹤0.01% 5812
2025
Q3 		– Hold
0
– – – 9795
2025
Q2 		– Hold
0
– – – 9375
2025
Q1 		– Sell
-4,273
Closed -$342K – 9000
2024
Q4 		$350K Buy
+4,273
New +$424K 0.01% 3469
2024
Q3 		– Sell
-2,473
Closed -$223K – 7936
2024
Q2 		$187K Buy
+2,473
New +$168K 0.01% 3452
2024
Q1 		– Hold
0
– – – 8487
2023
Q4 		– Hold
0
– – – 8771
2023
Q3 		– Hold
0
– – – 8961
2023
Q2 		– Hold
0
– – – 8929
2023
Q1 		– Hold
0
– – – 8458
2022
Q4 		– Hold
0
– – – 8574

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return